<DOC>
	<DOCNO>NCT01216865</DOCNO>
	<brief_summary>The purpose study determine whether umbilical cord Mesenchymal Stem Cells treatment diabetic foot safe effective management diabetic foot ischemia , therapeutic effect stem cell cause improve blood circulation ischemic limb would turn promote ulcer healing , prevent amputation limb relieve Sevier pain ischemia .</brief_summary>
	<brief_title>Umbilical Cord Mesenchymal Stem Cells Injection Diabetic Foot</brief_title>
	<detailed_description>Type 2 diabetic patient diabetic foot enrol randomize either transplant group control group . Patients transplant group receive stem cell treatment , Patients control group receive standard treatment . After culture vitro , umbilical cord mesenchymal stem cell go safety evaluation include culture check pathogenic microorganism ( bacteria , mycoplasma , chlamydia , eumycete virus ) cell medium karyotype analysis mesenchymal stem cell . Only safe cell harvest transplanted multiple intramuscular injection impair low limb . Follow-up index include : efficacy ( pain , ulcer heal rate , low limb amputation rate , ankle-brachial index , magnetic resonance angiography , electromyogram ) safety ( infection injection site , fever , tumour generation ) .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<criteria>Diabetes mellitus Type 2 Age 18 75 year Subject Anklebrachial index &lt; 0.9 Subject previous conservative treatment result little improvement Subject stem cell treatment within past 6 month No sufficient response best standard care deliver six week . No surgical radiological interventional option revascularisation confirm vascular surgeon interventional radiologist Signed informed consent Absence lifethreatening complication ischemic limb Life expectancy 2 year Negative pregnancy test applicable Diabetic retinopathy History neoplasm hematological disease Uncontrolled high blood pressure ( &gt; 180/110 ) Severe cardiac insufficiency ( New York Heart Association [ NYHA ] IV ) ejection fraction &lt; 30 % Malignant ventricular arrythmia Deep venous thrombosis last 3 month Active bacterial infection Body mass index &gt; 35 Kg/m2 Stroke myocardial infarction last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Diabetic foot</keyword>
	<keyword>critical limb ischemia</keyword>
	<keyword>mesenchymal stem cell</keyword>
	<keyword>umbilical cord</keyword>
</DOC>